Vanguard Group Inc Sqz Biotechnologies CO Transaction History

Vanguard Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.27 - $0.68 $179 - $452	-666 Reduced 0.07%	941,086 $254,000
Q4 2022 Feb 10, 2023	BUY	$0.67 - $2.85 $233 - $991	348 Added 0.04%	941,752 $696,000
Q2 2022 Aug 12, 2022	SELL	$2.77 - $5.0 $219,935 - $396,995	-79,399 Reduced 7.78%	941,404 $2.99 Million
Q1 2022 May 13, 2022	SELL	$4.01 - $10.42 $5,782 - $15,025	-1,442 Reduced 0.14%	1,020,803 $4.91 Million
Q4 2021 Feb 14, 2022	BUY	$8.93 - $14.85 $60,563 - $100,712	6,782 Added 0.67%	1,022,245 $9.13 Million
Q3 2021 Nov 12, 2021	BUY	$11.46 - $15.77 $1.43 Million - $1.97 Million	124,886 Added 14.02%	1,015,463 $14.6 Million
Q2 2021 Aug 13, 2021	BUY	$11.32 - $14.45 $10.1 Million - $12.9 Million	890,577 New	890,577 $12.9 Million

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.